One of the largest manufacturers of specialty-based aroma chemicals saw its shares plunge by over 9 percent after the company announced disappointing financial results. In this article, we will look at the financial performance of the company. As of March 2025, the company has a promoter holding of 74.17 percent.
With a market capitalization of Rs 1,319 crores, the shares of Oriental Aromatics Ltd are currently trading at Rs 392 per share, down by 40.33 percent from its 52-week high of Rs 656.70 per share. Over the past five years, the stock has delivered a return of 178 percent.
Financial Highlights
Oriental Aromatics reported a consolidated revenue of Rs 928 crores in FY25, up 10.21 percent from Rs 842 crores in FY24. On a year-on-year basis, revenue rose 16.95 percent to Rs 253.16 crores in Q4 FY25 from Rs 216.48 crores in Q4 FY24. On a sequential basis, revenue increased by 13.75 percent from Rs 222.57 crores in Q3 FY25.
The company posted a net profit of Rs 34 crores in FY25, up 277.78 percent from Rs 9 crores in FY24. On a year-on-year basis, however, net profit declined 86 percent to Rs 1.42 crores in Q4 FY25 from Rs 10.12 crores in Q4 FY24. Additionally, on a quarterly basis, its net profit declined by 80 percent from Rs 7.14 crores.
Also, the company has announced a dividend of Rs 0.5 per equity share, subject to the approval of the shareholders at the AGM of the company, and the management has set 8 August, Friday, 2025 as the record date.
Oriental Aromatics Limited is a leading Indian manufacturer of organic terpene chemicals, synthetic camphor, and specialty aroma ingredients. In the flavour and fragrance industry, Oriental Aromatics has a wide range of aroma chemicals, and camphor is also sold by the company for medicinal or religious usage. Its product range includes terpineol, pine oils, astromusk, and other aroma compounds that can be used for personal care, food, beverages, as well as home care products. Oriental Aromatics exports to over 30 countries, including the US, UK, China, and Brazil.
Written by Satyajeet Mukherjee
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
